登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603082 证券简称：北自科技 公告编号：2025-061 ■ 注：上表所列的词语或简称与重组报告书中定义的词语或简称含义相同。 特此公告。 北自所（北京）科技发展股份有限公司董事会 2025年11月6日 北自所（北京）科技发展股份有限公司 发行股份及支付现金购买资产并募集配套资金报告书（申报稿）的修订说明 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 北自所（北京）科技发展股份有限公司（以下简称"北自科技"或"公司"）拟发行股份及支付现金购买苏 州穗柯智能科技有限公司（以下简称"标的公司"）100%股权，并向不超过35名特定投资者发行股份募 集配套资金（以下简称"本次交易"）。 公司于2025年11月4日收到上海证券交易所出具的《关于受理北自所（北京）科技发展股份有限公司发 行股份购买资产并募集配套资金申请的通知》（上证上审（并购重组）〔2025〕88号），并于2025年11 月6日披露了《北自所（北京）科技发展股份有限公司发行股份及支付现金购买资产并募集配套资 ...

11月5日，北自科技涨0.59%，成交额2878.74万元。两融数据显示，当日北自科技获融资买入额433.18 万元，融资偿还262.18万元，融资净买入171.00万元。截至11月5日，北自科技融资融券余额合计1.21亿 元。 责任编辑：小浪快报 资料显示，北自所(北京)科技发展股份有限公司位于北京市西城区教场口街1号3号楼，成立日期2002年 10月23日，上市日期2024年1月30日，公司主营业务涉及以自动化立体仓库为核心的智能物流系统的研 发、设计、制造与集成业务。主营业务收入构成为：智能生产物流系统50.78%，智能仓储物流系统 47.13%，备件、运维及其他1.20%，智能物流装备0.80%，其他(补充)0.09%。 截至9月30日，北自科技股东户数1.37万，较上期减少18.19%；人均流通股2969股，较上期增加 22.24%。2025年1月-9月，北自科技实现营业收入14.02亿元，同比减少3.51%；归母净利润1.18亿元，同 比减少3.45%。 分红方面，北自科技A股上市后累计派现1.88亿元。 机构持仓方面，截止2025年9月30日，北自科技十大流通股东中，香港中央结算有限公司位居第三 ...

（文章来源：证券日报） 证券日报网讯 11月5日晚间，北自科技发布公告称，公司拟发行股份及支付现金购买苏州穗柯智能科技 有限公司100%股权，并向不超过35名特定投资者发行股份募集配套资金（简称"本次交易"）。2025年 11月4日，公司收到上海证券交易所出具的《关于受理北自所（北京）科技发展股份有限公司发行股份 购买资产并募集配套资金申请的通知》（上证上审（并购重组）〔2025〕88号），上海证券交易所依据 相关规定对本次交易的申请文件进行了核对，认为该项申请文件齐备，符合法定形式，决定予以受理并 依法进行审核。 ...

Group 1 - Triangle Defense signed a gas turbine project development and framework order agreement with Siemens Energy [1] - The development agreement allows Triangle Defense to qualify for supplying specific items to Siemens Energy, detailing technical prerequisites and standards [1] - Triangle Defense specializes in the research, production, and sales of forged products in aviation, aerospace, and shipping industries [1] Group 2 - Aerospace Hongtu was suspended from military procurement for three years due to alleged violations during a procurement activity [2] - The suspension will last from July 6, 2024, to July 6, 2027, affecting the company's participation in military material procurement [2] - Aerospace Hongtu focuses on satellite operations and data collection [3] Group 3 - Kaili Medical's executives purchased a total of 460,000 shares, investing approximately 13.15 million yuan [4] - The average purchase prices were 28.70 yuan and 28.53 yuan per share [4] - Kaili Medical is engaged in the research, production, and sales of medical diagnostic and treatment equipment [5] Group 4 - Muyuan Foods reported a 22.28% year-on-year decline in sales revenue from live pigs in October, totaling 10.33 billion yuan [6] - The average selling price of live pigs decreased by 32.73% year-on-year to 11.55 yuan per kilogram [6] - Muyuan Foods is involved in pig farming and slaughtering [7] Group 5 - Niuwei Co. plans to acquire 40% of its subsidiary Dongwu Machinery for 139 million yuan, aiming for full ownership [8] - Niuwei Co. specializes in the research, manufacturing, and sales of industrial valves [9] Group 6 - Jinlong Automobile reported a 14.71% year-on-year decline in bus sales in October, with 4,121 units sold [10] - Jinlong Automobile focuses on the production and sales of bus products [10] Group 7 - ST Tianshan reported a 242.54% year-on-year increase in sales revenue from live livestock in October, totaling 13.35 million yuan [11] - The company sold 1,367 head of livestock, marking a significant increase compared to previous periods [11] - ST Tianshan is involved in the breeding and sales of cattle and dairy products [12] Group 8 - Ningbo Port expects a 12.4% year-on-year increase in container throughput in October, reaching 4.56 million TEUs [13] - The total cargo throughput is projected to be 99.6 million tons, a 5.3% increase year-on-year [13] - Ningbo Port engages in port handling and logistics services [13] Group 9 - Amcare Pharma received approval for supplementary drug applications and clinical trials for its products [14] - The company is focused on new drug development and utilizes a MAH model for production [14] Group 10 - Lude Environment plans to change its stock name to "Lude Technology" while keeping its full name and stock code unchanged [15] - The company specializes in waste treatment and resource utilization technologies [15] Group 11 - Hualan Co. plans to increase its stake in the company by investing between 30 million and 60 million yuan [16] - The maximum purchase price is set at 58.08 yuan per share [16] - Hualan Co. focuses on the development and sales of packaging materials for injectable drugs [16] Group 12 - Caina Co. is using 140 million yuan of idle funds to purchase structured deposits from a bank, with expected annual yields between 0.70% and 1.85% [17] - Caina Co. specializes in the research, production, and sales of injection and laboratory consumables [17] Group 13 - Zhenghong Technology reported a 52.80% year-on-year decrease in sales revenue from live pigs in October, totaling 4.32 million yuan [18] - The company sold 400 head of pigs, marking a significant decline compared to previous periods [18] - Zhenghong Technology is involved in feed production and pig farming [18] Group 14 - Caida Securities received approval from the CSRC to issue bonds totaling up to 6 billion yuan [19] - The company is engaged in securities brokerage, investment banking, and asset management [19] Group 15 - Jiayuan Technology signed a copper foil supply framework agreement with CATL, establishing a long-term partnership [20] - The agreement includes collaboration in the supply and production of materials for new battery technologies [20] Group 16 - Haikong Group announced the resignation of its general manager due to personal career planning [21] - The company is involved in automotive passenger transport and related services [21] Group 17 - Beizhi Technology's application to acquire 100% of Suzhou Suike Intelligent Technology has been accepted by the Shanghai Stock Exchange [22] - The company specializes in intelligent logistics systems and equipment [22] Group 18 - Yikang Pharma's subsidiary received approval for clinical trials of a new injection for chronic hepatitis B [23] - The company focuses on the production and sales of raw and formulated pharmaceutical products [23] Group 19 - Hengyuan Coal Power plans to acquire 100% of two coal companies for 440 million yuan [24] - The acquisition includes assuming debts totaling 1.137 billion yuan [24] - Hengyuan Coal Power is involved in coal mining and sales [24] Group 20 - Yangpu Medical announced the cancellation of a production arrangement for a medical device [25] - The company specializes in precision medical and testing services [25] Group 21 - Kailong High-Tech plans to establish a 195 million yuan industry fund focusing on unlisted companies [26] - The company is involved in air pollution control and new energy management systems [26] Group 22 - Yingli Co. received approval for its application to acquire a majority stake in a company [27] - The company specializes in precision electronic components and related manufacturing [27] Group 23 - Tianyi Medical's arterial-venous puncture device received EU MDR certification, valid until January 2028 [28] - The company focuses on medical devices for blood purification and care [28] Group 24 - Chuangyuan Co. appointed a new president, effective until the end of the current board term [29] - The company specializes in the design and production of paper products [29] Group 25 - Shanghai Laishi's new indication for a drug received clinical trial approval [30] - The company focuses on the production and sales of blood products [30] Group 26 - Fengmao Co. plans to issue convertible bonds to raise up to 520 million yuan for expansion and working capital [31] - The company specializes in precision rubber components [31] Group 27 - Yinuo Si's shareholder plans to transfer 3% of the company's shares through an inquiry process [32] - The company provides comprehensive R&D services in the biopharmaceutical sector [32] Group 28 - Phoenix Shipping plans to use up to 50 million yuan of idle funds for cash management [33] - The company is involved in dry bulk shipping and logistics services [33] Group 29 - Xingyuan Zhuomei received a notification to supply magnesium alloy components worth 2.021 billion yuan to a new energy vehicle manufacturer [34] - The project is expected to start mass production in the third quarter of 2026 [34] Group 30 - Landai Technology's subsidiary plans to sell electric drive assembly assets for 110 million yuan [35] - The company specializes in power transmission and display technology [35] Group 31 - Yuexiu Capital plans to distribute a cash dividend of 0.90 yuan per share [36] - The company is involved in asset management and private equity [36] Group 32 - Northeast Securities plans to distribute a cash dividend of 1.00 yuan per share, totaling 234 million yuan [37] - The company focuses on wealth management and investment banking [37] Group 33 - Jinguang Electric won a bid for a project from the State Grid worth 21.7976 million yuan [38] - The company specializes in the research and manufacturing of power distribution equipment [39] Group 34 - Huarong Co. plans to repurchase shares worth between 40 million and 125 million yuan [40] - The company focuses on the production and sales of explosion-proof electrical equipment [40] Group 35 - Baiyang Pharma signed a distribution agreement for a blood product, gaining exclusive rights in specific markets [41] - The company specializes in the development and commercialization of medical innovations [41] Group 36 - Li Qun Co.'s director plans to reduce his stake by up to 71,000 shares due to personal financial needs [42] - The company is involved in retail and logistics services [42] Group 37 - Su Li Co.'s shareholder plans to reduce his stake by up to 0.48% of the company's shares [43] - The company specializes in the production and sales of fine chemical products [43] Group 38 - Shenzhen Ruijie obtained a commitment letter for a stock repurchase loan of up to 15.3 million yuan [44] - The company provides project management and evaluation services [44] Group 39 - Fudan Zhangjiang's shareholder plans to reduce his stake by up to 1% of the company's shares [45] - The company focuses on biopharmaceutical research and development [45] Group 40 - Ningbo Zhongbai's shareholder plans to reduce his stake by up to 1% of the company's shares [46] - The company is involved in retail and wholesale operations [46] Group 41 - Jingyi Co. announced a change in control due to a judicial auction of shares [47] - The company specializes in copper processing and digital carbon services [47] Group 42 - Luoping Zinc Electric's subsidiary obtained a new safety production license for mining operations [48] - The company focuses on hydropower and mining activities [48]

公司名称：北自所（北京）科技发展股份有限公司 股票简称：北自科技 上市地点：上海证券交易所 股票代码：603082.SH 北自所（北京）科技发展股份有限公司 发行股份及支付现金购买资产 并募集配套资金报告书 （申报稿） | 交易对方类型 | 交易对方/发行对象名称 | | --- | --- | | 发行股份及支付现金购买资产 | 翁忠杰、刘庆国、冯伟 | | 募集配套资金 | 不超过 35 名符合条件的特定对象 | 独立财务顾问 签署日期：二〇二五年十月 北自所（北京）科技发展股份有限公司 发行股份及支付现金购买资产并募集配套资金报告书（草案） 上市公司声明 本公司及全体董事、高级管理人员承诺并保证本报告书及其摘要内容的真实、 准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并对其真实性、准确性 和完整性承担相应的法律责任。 本公司控股股东及全体董事、高级管理人员承诺：如本次交易所提供或披露 的信息涉嫌虚假记载、误导性陈述或者重大遗漏，并被司法机关立案侦查或者被 中国证监会立案调查的，在形成调查结论以前，不转让在上市公司拥有权益的股 份，并于收到立案稽查通知的两个交易日内将暂停转让的书面申请和股票账户提 ...

北京市君合律师事务所 关于北自所（北京）科技发展股份有限公司 发行股份及支付现金购买资产并募集配套资金的 法律意见书 二零二五年十月 2-2-1 | 一、本次交易的方案 | 9 | | --- | --- | | （一）整体方案 | 9 | | （二）本次发行股份及支付现金购买资产方案 | 9 | | （三）募集配套资金具体方案 | 15 | | （四）业绩承诺及其可实现性 | 17 | | （五）过渡期损益安排的合理性 | 17 | | （六）本次重组不构成重大资产重组 | 18 | | （七）本次重组不构成重组上市 | 18 | | （八）本次交易不构成关联交易 | 18 | | （九）相关主体的股份减持计划 | 18 | | （十）结论 | 18 | | 二、本次交易各方的主体资格 | 19 | | （一）本次股份发行方及资产购买方 | 19 | | （二）本次交易的交易对方 | 25 | | （三）结论 | 25 | | 三、关于本次交易的授权与批准 | 25 | | （一）已经取得的授权与批准 | 25 | | （二）尚待取得的批准或备案 | 26 | | （三）结论 | 26 | | 四、本次交易 ...

国泰海通证券股份有限公司 关于 北自所（北京）科技发展股份有限公司 发行股份及支付现金购买资产 并募集配套资金 之 独立财务顾问报告 独立财务顾问 二〇二五年十月 独立财务顾问声明和承诺 国泰海通证券股份有限公司（以下简称"国泰海通"、"本独立财务顾问"） 接受北自所（北京）科技发展股份有限公司（以下简称"北自科技"、"上市公 司"或"公司"）委托，担任本次发行股份及支付现金购买资产并募集配套资金 （以下简称"本次交易"）的独立财务顾问，就该事项向上市公司全体股东提供 独立意见，并制作本独立财务顾问报告。 本独立财务顾问核查意见是依据《中华人民共和国公司法》《中华人民共和 国证券法》《上市公司重大资产重组管理办法》《上市公司并购重组财务顾问业 务管理办法》《公开发行证券的公司信息披露内容与格式准则第 26 号——上市 公司重大资产重组》《上市公司监管指引第 9 号——上市公司筹划和实施重大资 产重组的监管要求》和《上海证券交易所上市公司重大资产重组审核规则》等法 律法规及文件的规定和要求，以及证券行业公认的业务标准、道德规范，经过审 慎调查，本着诚实信用和勤勉尽责的态度，就本次交易认真履行尽职调查义务， 对上 ...

证券代码：603082 证券简称：北自科技 公告编号：2025-061 北自所（北京）科技发展股份有限公司 发行股份及支付现金购买资产并募集配套资金报告 书（申报稿）的修订说明 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 北自所（北京）科技发展股份有限公司（以下简称"北自科技"或"公司"） 拟发行股份及支付现金购买苏州穗柯智能科技有限公司（以下简称"标的公司"） 100%股权，并向不超过 35 名特定投资者发行股份募集配套资金（以下简称"本 次交易"）。 公司于 2025 年 11 月 4 日收到上海证券交易所出具的《关于受理北自所（北 京）科技发展股份有限公司发行股份购买资产并募集配套资金申请的通知》（上 证上审（并购重组）〔2025〕88 号），并于 2025 年 11 月 6 日披露了《北自所（北 京）科技发展股份有限公司发行股份及支付现金购买资产并募集配套资金报告书 （申报稿）》（以下简称"申报稿"）等文件。 相较公司于 2025 年 10 月 11 日披露的《北自所（北京）科技发展股份有限 公司发行股份及支付现金 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 2025 年 11 月 6 日 北自所（北京）科技发展股份有限公司（以下简称"北自科技"或"公司"） 拟发行股份及支付现金购买苏州穗柯智能科技有限公司（以下简称"标的公司"） 100%股权，并向不超过 35 名特定投资者发行股份募集配套资金（以下简称"本 次交易"）。 2025 年 11 月 4 日，公司收到上海证券交易所出具的《关于受理北自所（北 京）科技发展股份有限公司发行股份购买资产并募集配套资金申请的通知》（上 证上审（并购重组）〔2025〕88 号），上海证券交易所依据相关规定对本次交易 的申请文件进行了核对，认为该项申请文件齐备，符合法定形式，决定予以受理 并依法进行审核。 本次交易尚需上海证券交易所审核通过及中国证券监督管理委员会同意注 册后方可正式实施。公司将继续推进本次交易的相关工作，并严格按照相关法律 法规的规定和要求履行信息披露义务，有关信息均以在公司指定信息披露媒体刊 登的公告为准。敬请广大投资者关注公司后续公告并注意投资风险。 特此公告。 证券代码：60 ...

北自科技公告，公司拟发行股份及支付现金购买苏州穗柯智能科技有限公司100%股权，并向不超过35 名特定投资者发行股份募集配套资金。2025年11月4日，公司收到上海证券交易所出具的《关于受理北 自所（北京）科技发展股份有限公司发行股份购买资产并募集配套资金申请的通知》，上海证券交易所 决定予以受理并依法进行审核。本次交易尚需上海证券交易所审核通过及中国证券监督管理委员会同意 注册后方可正式实施。 ...